Premium
Prescribing in COVID‐19 patients: Should we take into account inflammation?
Author(s) -
Marzolini Catia,
Battegay Manuel,
Sendi Parham,
Back David J.
Publication year - 2021
Publication title -
british journal of clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.216
H-Index - 146
eISSN - 1365-2125
pISSN - 0306-5251
DOI - 10.1111/bcp.14524
Subject(s) - medicine , drug , pharmacology , cyp3a4 , molecular pharmacology , inflammation , clinical pharmacology , pharmacokinetics , covid-19 , clinical trial , disease , bioinformatics , intensive care medicine , immunology , cytochrome p450 , receptor , biology , metabolism , infectious disease (medical specialty)
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom